CATALYST BANCORP INC (CLST) Stock Fundamental Analysis

USA Nasdaq NASDAQ:CLST • US14888L1017

15.82 USD
0 (0%)
Last: Feb 9, 2026, 04:30 PM
Fundamental Rating

2

Overall CLST gets a fundamental rating of 2 out of 10. We evaluated CLST against 381 industry peers in the Banks industry. The financial health of CLST is average, but there are quite some concerns on its profitability. CLST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CLST had positive earnings in the past year.
  • CLST had a positive operating cash flow in the past year.
  • In multiple years CLST reported negative net income over the last 5 years.
  • In the past 5 years CLST always reported a positive cash flow from operatings.
CLST Yearly Net Income VS EBIT VS OCF VS FCFCLST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

  • CLST has a Return On Assets (0.78%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 2.72%, CLST is doing worse than 85.30% of the companies in the same industry.
Industry RankSector Rank
ROA 0.78%
ROE 2.72%
ROIC N/A
ROA(3y)-0.28%
ROA(5y)-0.1%
ROE(3y)-1.01%
ROE(5y)-0.49%
ROIC(3y)N/A
ROIC(5y)N/A
CLST Yearly ROA, ROE, ROICCLST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 2 -2

1.3 Margins

  • CLST has a Profit Margin of 19.66%. This is in the lower half of the industry: CLST underperforms 67.45% of its industry peers.
  • CLST does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 19.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLST Yearly Profit, Operating, Gross MarginsCLST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 -40

5

2. Health

2.1 Basic Checks

  • CLST does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CLST has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CLST has less shares outstanding
  • There is no outstanding debt for CLST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLST Yearly Shares OutstandingCLST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
CLST Yearly Total Debt VS Total AssetsCLST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • There is no outstanding debt for CLST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC12.08%
CLST Yearly LT Debt VS Equity VS FCFCLST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CLST Yearly Current Assets VS Current LiabilitesCLST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2M 4M 6M 8M

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 170.19% over the past year.
  • Looking at the last year, CLST shows a very strong growth in Revenue. The Revenue has grown by 104.49%.
  • The Revenue has been decreasing by -6.56% on average over the past years.
EPS 1Y (TTM)170.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.77%
Revenue 1Y (TTM)104.49%
Revenue growth 3Y-15.72%
Revenue growth 5Y-6.56%
Sales Q2Q%-12.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLST Yearly Revenue VS EstimatesCLST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 26.37, which means the current valuation is very expensive for CLST.
  • Based on the Price/Earnings ratio, CLST is valued more expensive than 85.04% of the companies in the same industry.
  • CLST's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 26.37
Fwd PE N/A
CLST Price Earnings VS Forward Price EarningsCLST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLST indicates a slightly more expensive valuation: CLST is more expensive than 74.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.53
EV/EBITDA N/A
CLST Per share dataCLST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • CLST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CATALYST BANCORP INC

NASDAQ:CLST (2/9/2026, 4:30:00 PM)

15.82

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-29
Earnings (Next)N/A
Inst Owners21.94%
Inst Owner Change15.98%
Ins Owners6.6%
Ins Owner Change-0.68%
Market Cap65.02M
Revenue(TTM)11.30M
Net Income(TTM)2.22M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.37
Fwd PE N/A
P/S 5.75
P/FCF 22.53
P/OCF 20.8
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)0.6
EY3.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY4.44%
OCF(TTM)0.76
OCFY4.81%
SpS2.75
BVpS19.85
TBVpS19.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number16.37
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 2.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 19.66%
GM N/A
FCFM 25.53%
ROA(3y)-0.28%
ROA(5y)-0.1%
ROE(3y)-1.01%
ROE(5y)-0.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 57.01%
Cap/Sales 2.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 129.88%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC12.08%
ROIC/WACCN/A
Cap/Depr(3y)67.53%
Cap/Depr(5y)143.85%
Cap/Sales(3y)4.11%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)104.49%
Revenue growth 3Y-15.72%
Revenue growth 5Y-6.56%
Sales Q2Q%-12.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122%
FCF growth 3Y12.61%
FCF growth 5YN/A
OCF growth 1Y112.65%
OCF growth 3Y-2.57%
OCF growth 5Y13.15%

CATALYST BANCORP INC / CLST FAQ

What is the ChartMill fundamental rating of CATALYST BANCORP INC (CLST) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLST.


Can you provide the valuation status for CATALYST BANCORP INC?

ChartMill assigns a valuation rating of 0 / 10 to CATALYST BANCORP INC (CLST). This can be considered as Overvalued.


How profitable is CATALYST BANCORP INC (CLST) stock?

CATALYST BANCORP INC (CLST) has a profitability rating of 2 / 10.


What are the PE and PB ratios of CATALYST BANCORP INC (CLST) stock?

The Price/Earnings (PE) ratio for CATALYST BANCORP INC (CLST) is 26.37 and the Price/Book (PB) ratio is 0.8.


What is the financial health of CATALYST BANCORP INC (CLST) stock?

The financial health rating of CATALYST BANCORP INC (CLST) is 5 / 10.